BRAIN NAVI is selected by Mayo Clinic and ASU MedTech Accelerator
Brain Navi Biotechnology is selected to be the Mayo Clinic and ASU MedTech Accelerator
Brain Navi Biotechnology Co., Ltd.
Brain Navi Biotechnology is the leading surgical robot company in Taiwan, focusing on developing innovative solutions to improve patient outcomes in neurosurgery. We are dedicated to making neurosurgical procedures more efficient, precise, and accessible. Brain Navi was founded in 2015, located in Hsinchu Biomedical Science Park.
Brain Navi mainly focuses on designing and developing medical devices that can assist surgeons during their medico-surgical interventions, with the outstanding doctors, researchers, and developers in Taiwan to combine technical and clinical application experience, developing products driven by demand.
Our Mission
Improve Accuracy
Streamline Surgical Procedures
Reduce the Learning Curves
Designed and Developed in Taiwan
In 2018, Brain Navi Biotechnology developed NaoTrac, the first Autonomous surgical navigation robot with machine vision specially designed for cranial neurosurgery. Until current research, it is enough to fit in the routine clinical setting. Brain Navi Biotechnology is mainly focusing on developing and researching innovative neurosurgical navigation system.
With the outstanding doctors, researchers, and developers in Taiwan to combine technical and clinical application experience, developing products driven by demand. Takes Taiwan’s advantages in R&D and production in the electronics industry, selecting Taiwan as a research and development and production base. Brain Navi will focus on the global market and create sustainable value management.
Milestones
2024
year
100 NaoTrac Surgeries
From the first in human case on 7 Nov 2018 to the 100 case on 10 Jan 2024, NaoTrac has been used routinely in clinical cases such as ICH treatment, EVD, brain tumor biopsy, stem cell implantation and so on. We celebrate this very important milestone with all neurosurgeons participated in this journey. To help more patients, welcome to contact us for the distribution information. Let's save more lives.
2023
year
BRAIN NAVI received National Pharmaceutical Science and Technology Research and Development Award
Brain Navi Team Exhibited in EANS Annual Meeting
This is the first time that Brain Navi debuted NaoTrac in EANS ( European Association of Neurosurgical Societies)
Brain Navi received National Innovation Award 2023
Brain Navi received National Innovation Award renewal and issue the Excelsior Award in recognition of continuing innovations.
NaoTrac Installation in An-Nan Hospital
NaoTrac installed in An-Nan Hospital in Tainan, and proceeded the first neurosurgery.
2022
year
Bestchain Healthtaiwan Co., Ltd. becomes Taiwan general distributor of Brain Navi
Bestchain HealthTaiwan from Bestchain Medical Group becomes the general distributor partnership with Brain Navi in Taiwan market!
NaoTrac Taiwan FDA approval
NaoTrac achieved the Taiwan FDA in the end of June, 2022
2021
year
NaoTrac CE mark Certification
NaoTrac, the surgical navigation Robot, received the certificate CE mark.
2020
year
SNQ symbol
NaoTrac, the surgical navigation robot, received Symbol of National Quality of Taiwan.
2019
year
Congress Neurology Surgeon 2019 Annual Meeting
Participated CNS (Congress Neurology Surgeon 2019) Annual Meeting 2019 in Moscone Center, San Francisco, the United States. The First time published the clinical trial result of NaoTrac.
Signed the MOU with SMHeuristics
Signed the MOU with SMHeuristics from Boise, Idaho of the United States. The MOU is for further sales cooperation in USA medical device market.
ISO factory & ISO 13485 certified
Brain Navi Biotechnology officially becomes standard ISO factory, ISO 13485 certified.
2018
year
First-in-Human clinical trial
NaoTrac performed the First-in-Human clinical trial at Hualien Tzu Chi Hospital, Taiwan.
President on-site visiting
President Ing-Wen Tsai visited Brain Navi in the Hsinchu Biomedical Science Park, demonstrating NaoTrac.
2017
year
TechCrunch Disrupt
Participated "TechCrunch Disrupt" in San Francisco, selected by Taiwanese Ministry of Science and Technology.
First-in-animal experiment test
First-in-animal experiment test of NaoTrac in brain surgery. Accurately matched to 2mm tolerance, successfully qualified ASTM requirements.
Management Team
Nelson Farfan Espada
CMO
MD. Jerry Chen
CEO
Chia-Yu Chang
VP of Strategic Investment
Virginia Chang
Administration Manager
Bokhan Zorlubas
BD Manager
Craig Hsu
Production Manager
Partners and Collaborations
